Press Release Oct 27 2025
Filed with NSE · · 3 pages · English
Summary by 6ix AI
SAI Life Sciences Ltd. has announced the groundbreaking of a new CMC Process R&D Center in Hyderabad, which will double its Process R&D capacity and introduce new capabilities in various areas of drug development. This strategic investment reflects the company's strong business momentum and expanding partnerships with global pharmaceutical and biotech companies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from SAI Life Sciences
- Sai Life Sciences Set to Double Process R&D Capacity With New Facility in Hyderabad
- Press Release Oct 08 2025
- Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators
- Press Release Sep 18 2025
- Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India
Later from SAI Life Sciences
- Press Release Nov 06 2025
- Press Release Nov 11 2025
- Sai Life Sciences Releases Sustainability Report 2024–25
- Press Release Dec 19 2025
- Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site
Follow SAI Life Sciences into a list and get an email when it puts out news.
Follow SAI Life Sciences